Very surprised: MRNA is up so much today.

Moderna gains on report it held talks with at least one large drugmaker

 

 

Update 12:30pm: Adds Moderna cancelling from a conference.

• Moderna (MRNA) rose 12% after a report that it has held talks with at least one large drugmaker on a deal of "significant scope," according to a STAT News report.
• A takeover or a large partnership was on the table, according to the STAT News item on Thursday, which cited one person familiar with the discussions. The precise nature of the potential agreement was unclear.
• Moderna didn't immediately respond to Seeking Alpha's request for comment.
• Separately on Thursday, Moderna (MRNA) cancelled from a UBS Global Healthcare conference scheduled for Nov. 9 - Nov. 12 in Palm Beach Gardens, Florida. Moderna cancelled from the conference due to scheduling conflicts, according to an email viewed by Seeking Alpha.